Collegium Pharmaceutical, Inc.

COLL

$23.99

+1.23%

N/A+$0.29

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Active Trading

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse ...

Key Metrics of COLL

Snapshot

Latest / TTM · 6 periods

Market Cap

$778.11M

ROCE

10.3%

EV / EBITDA

2.57x

-5.1% YoY

FCF Yield

42.2%

+19.9% YoY

Cash Conversion Cycle

246.3d

Current Ratio

1.03

Quick take

TTM —

Positive CCC

Key Metrics

Latest / TTM · 6 periods

Valuation trend

Valuation trend table

Metric	2021	2022	2023	2024	2025	TTM
Market CapTotal market value of all shares outstanding.	$652.62M	$784.84M	$1.04B	$924.65M	$1.47B	$778.11M
Enterprise ValueCompany value including debt and cash adjustments.	$724.94M	$1.32B	$1.47B	$1.71B	$2.16B	$1.51B
EV / SalesHow many dollars investors pay per dollar of sales.	2.62x	2.85x	2.60x	2.71x	2.76x	1.86x
EV / EBITDAValuation multiple versus operating earnings before non-cash charges.	8.38x	7.62x	4.78x	5.01x	5.38x	2.57x
Net Debt / EBITDALeverage ratio using net debt divided by EBITDA.	0.84	3.09	1.41	2.31	1.72	1.24

Returns + ROCE gauge

ROCE latest

10.3%

Prev year 15.4%

Returns + ROCE gauge table

Metric	2021	2022	2023	2024	2025	TTM
ROEProfit generated from shareholders' equity.	35.2%	-12.8%	24.6%	30.2%	20.8%	16.0%
ROAProfit generated from total assets.	10.3%	-2.1%	4.2%	4.2%	3.8%	2.2%
ROICReturn generated on invested operating capital.	-112.7%	4.2%	15.4%	11.6%	11.0%	10.5%
ROCEOperating return on long-term capital used.	4.3%	4.5%	24.4%	14.7%	15.4%	10.3%
Earnings YieldEarnings as a percentage of market value.	11.0%	-3.2%	4.6%	7.5%	4.3%	6.2%

Cash flow quality

Cash flow quality table

Metric	2021	2022	2023	2024	2025	TTM
FCFFCash flow available to all capital providers.	$-343.81M	$177.40M	$327.28M	$255.25M	$383.46M	$428.17M
FCFECash flow available to equity holders after debt flows.	$51.61M	$565.29M	$208.37M	$210.85M	$257.20M	$575.19M
FCF YieldFree cash flow divided by market capitalization.	15.6%	15.6%	26.4%	22.0%	22.3%	42.2%
Income QualityHow well accounting earnings are backed by cash flow.	1.45	-4.97	5.71	2.96	5.24	6.89
Capex / OCFShare of operating cash flow spent on capital expenditures.	1.9%	1.3%	0.2%	0.8%	0.5%	0.5%

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	TTM
DSOAverage days to collect cash from customers.	139.5d	144.1d	115.6d	132.1d	98.8d	128.8d
DIOAverage days inventory stays before being sold.	50.3d	66.7d	49.0d	51.1d	47.1d	127.9d
DPOAverage days the company takes to pay suppliers.	12.1d	5.0d	13.2d	5.7d	12.3d	10.4d
Operating CycleTime from buying inventory to collecting receivables.	189.8d	210.8d	164.7d	183.2d	145.9d	256.7d
Cash Conversion CycleNet days cash is tied in operations.	177.7d	205.8d	151.5d	177.5d	133.6d	246.3d

Snapshot

Latest / TTM: —

Market Cap

$778.11M

ROE

16.0%

FCF Yield

42.2%

Current Ratio

1.03

Upstream

Patheon (Thermo Fisher Scientific)NYSE:TMOGrünenthal GmbHShionogi & Co., Ltd.TSE:4507Belbuca Third-Party Manufacturer(s)Jornay PM Third-Party Manufacturer(s)Nucynta Third-Party Manufacturer(s)Symproic Manufacturer (Shionogi supply chain)TSE:4507Buprenorphine API Supplier(s)Oxycodone API Supplier(s)Tapentadol API Supplier(s)Methylphenidate HCl API Supplier(s)

Downstream

McKesson CorporationNYSE:MCK Cencora, Inc. (formerly AmerisourceBergen)NYSE:COR Cardinal Health, Inc.NYSE:CAHHikma Pharmaceuticals PLCLSE:HIKExpress Scripts (Cigna)NYSE:CI CVS CaremarkNYSE:CVS Optum Rx (UnitedHealth Group)NYSE:UNH

Proxies

Thermo Fisher Scientific Inc.NYSE:TMO Cencora, Inc.NYSE:CORHikma Pharmaceuticals PLCLSE:HIKShionogi & Co., Ltd.TSE:4507

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Collegium Pharmaceutical, Inc.

Key Metrics of COLL

Key Metrics

Valuation trend

Returns + ROCE gauge

Cash flow quality

Operating efficiency

Snapshot

Supply Chain of COLL

Upstream

Downstream

Proxies

Key Metrics of COLL

Key Metrics

Valuation trend

Returns + ROCE gauge

Cash flow quality

Operating efficiency

Snapshot

Supply Chain of COLL

Upstream

Downstream

Proxies